Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Smiles: CN(C1C=CC(=CC=1)NC(=O)NC1C=CC(=CC=1)OC(F)(F)F)C1=CC=NC(NC2C=C(C=CC=2)S(N)(=O)=O)=N1
486427-17-2
LBQ657 modestly inhibits cardiac myocyte hypertrophy
20-lyase inhibitors
whereas the response to VU-0357121 is not altered by the F585I/rmGlu5 mutation
MK 2206 Size:Solid 10 mg Smiles: CN(C1C=CC(=CC=1)NC(=O)NC1C=CC(=CC=1)OC(F)(F)F)C1=CC=NC(NC2C=C(C=CC=2)S(N)(=O)=O)=N1MK2206 is a Akt inhibitor, is also an orally bioavailable allosteric inhibitor of the serine threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. Akt inhibitor MK2206 binds to and inhibits the activity of Akt in a non ATP competitive manner, which may result in the inhibition of the PI3K Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Product information CAS Number:
US$ 352.50
US$ 114.00
US$ 111.00
US$ 388.50
US$ 474.50
US$ 157.00
US$ 1141.00
US$ 111.00
US$ 573.00
US$ 558.88